FDA to Hold Public Meeting on Enhancing Demographic Data Collection

Summary

The FDA is seeking public feedback on its progress in implementing a plan to collect and analyze demographic subgroup data, as required by the Food and Drug Administration Safety and Innovation Act, and is inviting comments from patient groups, consumer groups, industry, academia, and other stakeholders.